News

• June 20, 2017

GE Ventures, Mayo Clinic Ventures and DFJ invest $13.75M in first software platform to accelerate cancer cure process and delivery

• June 20, 2017

Vineti takes aim at cancer cell-therapy market with $13.8 million Series A

• June 20, 2017

GE Ventures spin-out Vineti raises $13.75M for complex biomanufacturing

• June 20, 2017

GE and the Mayo Clinic back software to bring cancer-fighting gene therapies to market

• January 12, 2017

Vineti (formerly Vitruvian Networks) presents at Phacilitate Cell & Gene Therapy World 2017 Conference

• December 23, 2016

Kite Pharma and Vitruvian Networks enter strategic partnership to develop best-in-class logistics and data analytics software for engineered T-cell therapies at commercial scale

• October 4, 2016

Meeting on the Mesa

• April 29, 2016

Vineti (formerly Vitruvian Networks) presents at Phacilitate Cell & Gene Therapy World 2017 Conference

• April 11, 2016

New digital company attacks hard-to-kill cancer with software

• April 11, 2016

GE Ventures and Mayo Clinic launch company to scale and digitize cell and gene therapy